Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variations and irregular X chromosome activity may contribute to hair loss in women who can have children.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

Sansevieria trifasciata Prain shows promise for treating hair loss by inhibiting androgen receptors.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Higher levels of heat shock protein 27 and lower levels of miR-1 can increase AR levels, leading to hair loss in men.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Certain gene variations might be linked to severe acne in women but not in men.

Mutations in certain receptors can cause diseases and offer new treatment options.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Testosterone reduces knee flexibility by affecting relaxin receptors.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

AR gene not major factor in female hair loss; different from male hair loss.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Differences in androgen receptor expression and tissue properties may lead to higher cryptorchidism risk in certain rats.

Clascoterone 1% cream is a promising new treatment for acne.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.